Longevity Bros
Home › Glossary › Fisetin
Glossary

Fisetin: the strawberry flavonoid on trial as a senolytic

Fisetin is the senolytic sold without a prescription, which has made it popular well ahead of the trials. The mouse data are good; the human results are not yet in.

Reviewed by the Longevity Bros team · Updated 1 October 2026

Before you read onResearch and educational information for adults, not medical advice. This entry explains one longevity term — what it means, why it matters and what the evidence says — and nothing here diagnoses, treats, cures or prevents any condition. Baseline labs come before anything, and your own physician has the final word. Longevity Bros offers coaching and written research protocols only — we do not sell, supply, source or ship any compound.

What it means

Fisetin is a flavonol found in strawberries, apples, persimmons and onions, in small amounts. In 2018 a screen of natural compounds at the Mayo Clinic identified it as the most potent senolytic among them in cultured cells, and the follow-up in mice made it a longevity-supplement staple.

Supplements provide 100–500 mg per capsule; trial protocols use far more — around 20 mg per kg of body weight for two consecutive days, repeated monthly — on the "hit-and-run" senolytic model.

Why it matters for longevity

If a food-derived flavonoid could clear senescent cells in people, it would be the first accessible senolytic. That is why fisetin has more registered human trials than any other senolytic candidate, including trials in frailty, osteoarthritis, kidney function and post-COVID recovery.

What the evidence says

Yousefzadeh 2018 (EBioMedicine): fisetin reduced senescent-cell markers in aged mice and extended median lifespan by about 10% when started late in life. It also lowered inflammatory markers and improved tissue function in several mouse models.

Human data: a 2023 trial in osteoarthritis (fisetin 20 mg/kg, two days) found reduced inflammatory markers but no significant functional benefit; the Mayo AFFIRM-LITE frailty trial has not published its main results. Oral bioavailability is poor — most fisetin is metabolised before it reaches tissue — and no trial has yet shown reduced senescent-cell burden in human tissue after oral fisetin.

How to measure or use it

Related

Frequently asked questions

Does fisetin work in humans?

Not yet shown. Mouse data are positive; the completed human trials are small and have not demonstrated senolytic effects or clear functional benefit.

What dose is used in trials?

About 20 mg per kg of body weight on two consecutive days, repeated monthly. Supplement capsules are a fraction of that.

Is it the same as quercetin?

Related flavonols with overlapping actions. Quercetin's senolytic evidence is as part of the dasatinib combination; fisetin was tested alone.

Your own protocol

Want this applied to your own numbers?

Fifteen minutes of intake, your labs, a human-reviewed protocol within about 24 hours, three documents, a free coach call and check-ins through the cycle. €399, follow-up included.

Build my protocol Book a 15-minute call